Back to news
Two ICREA spin offs obtain funding from H2020 SME support instrument. The entrepreneurs Laura Soucek (ICREA at VHIO) and Roger Gomis (ICREA at IRB) have both secured a bunch of money from H2020 SME instrument this week. Their two companies are attacking different aspects of cancer tumors. Inbiomotion, Roger’s company is testing a platform to prevent breast cancer from invading bone marrow. Peptomyc, Laura’s company, has invented an innovative mollecule that blocks one of the most critical oncogenes, applicable to a wide array of different tumors.
Congratulations Laura and Roger, and keep up the good work!
More details? Click here.
OTHER NEWS
LuxQuanta raises €8M to deploy quantum cyber security solutions
This ICFO spin-off is based on research led by ICREA Research Professor Valerio Pruneri, who is also a founding member…
Spanish National Research Awards 2025
Three ICREA Research Professors awarded the Spanish National Research Award and the Spanish National Youth Research. Congratulations to: · Josep…
